First Eagle Investment Management Adds $9M in Bio-Rad Laboratories, Inc. ($BIO)

Key Points

  • First Eagle Investment Management changed its Bio-Rad Laboratories, Inc. ($BIO) stake by 1.3% last quarter, boosting to 2,602,772 shares worth $744.24 million.
  • $BIO last traded around $285.94.

First Eagle Investment Management increased its position in Bio-Rad Laboratories, Inc. ($BIO) by 1.3% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,602,772 shares of Bio-Rad Laboratories, Inc. after buying 32,299 shares during the quarter. First Eagle Investment Management's holdings in Bio-Rad Laboratories, Inc. were worth $744.24 million as of its most recent filing.

Bio-Rad Laboratories, Inc. ($BIO) Stock

Last price$285.94
Market cap$7.65B
P/E ratio47.66
Forward P/E29.41
PEG ratio4.01
Beta1.08
52-week low$222.80
52-week high$343.12
50-day MA$282.83
200-day MA$293.86
Current ratio3.21
Quick ratio2.19
Debt-to-equity0.20

Bio-Rad Laboratories, Inc. Earnings

EPS (ttm)$6.00
Revenue (ttm)$2.59B
Revenue growth1.1%
Net margin6.5%
Return on equity2.5%
Next earningsJul 30, 2026

Analysts Set New Price Targets

Average target$297.00
High target$320.00
Low target$275.00
Analysts covering5

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

ExchangeNYSE
SectorHealthcare
IndustryMedical Devices
HeadquartersHercules, CA
CEOMr. Norman D. Schwartz
Employees7,450

See Also

This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.